Gatehouse Bio Company

Gatehouse Bio is a biotechnology company focused on advancing precision medicine to accelerate the development of next-gen therapeutics. Their technology is based on a patented, revolutionary approach to uncover small RNA (sRNA) signatures of disease using biology influenced machine learning. sRNA signatures provide a platform for drug discovery and drug repurposing, and have been validated in cardiology, neurology, oncology, respiratory and rare diseases by industry leaders and the FDA. They have unique business model that promotes collaboration with leading drug developers to identify novel drug targets and discover companion diagnostics.
Technology: Biotechnology
Industry: Data Processing
Headquarters: Waltham, Massachusetts, United States
Founded Date: 2016-04-16
Employees Number: 1-10
Funding Status: Early Stage Venture
Investors Number: 3
Total Funding: 7945379
Estimated Revenue: Less than $1M
Last Funding Date: 2021-01-15
Last Funding Type: Series A

Visit Website
neal.foster@gatehousebio.com
Register and Claim Ownership